SQUAWK/NEWS
Menu
Live News EQUITY L impact

AN2 Therapeutics initiated with bullish view at Guggenheim

AN2 Therapeutics initiated with bullish view at Guggenheim

ANTX.USEQUIT

AN2 Therapeutics initiated with bullish view at Guggenheim